沙门氏菌检测市场 - 全球产业规模、份额、趋势、机会及预测（按检测方法、样品类型、最终用户、地区和竞争格局划分，2021-2031年）

全球沙门氏菌检测市场预计将从 2025 年的 33.1 亿美元成长到 2031 年的 47.2 亿美元，复合年增长率为 6.09%。

该市场涵盖用于检测食品、饮料、水源和临床检体中沙门氏菌的诊断技术、耗材和检测方法。推动这一增长的关键因素包括日益严格的国际食品安​​全法规、全球食源性疾病爆发频率的增加以及消费者对透明食品卫生规范日益增长的需求。因此，在整个供应链中进行严格的病原体筛检已成为强制性要求，可靠且快速的检测解决方案对于避免污染和保护公众健康至关重要。

儘管前景广阔，但先进分子诊断平台的高昂营运成本构成了市场准入的一大障碍，限制了其在成本敏感发展中地区的普及。 2024年美国国家鸡肉委员会的数据显示，在加工厂检测的鸡肉中，97%的鸡肉和93%的鸡肉部位沙门氏菌检测结果为阴性，这表明维持如此高的安全水平需要大量的检测工作。虽然这些结果凸显了该行业对持续检验的依赖，但如此全面的检测项目所带来的经济负担仍然是小规模市场参与企业的一大障碍。

市场驱动因素

各国政府严格的食品安全法规的实施是推动全球沙门氏菌检测市场扩张的主要动力。世界各地的监管机构正在降低沙门氏菌的检出阈值，并对某些血清型实施「零容忍」政策，迫使生产商采用高灵敏度的分子筛检通讯协定。这种监管环境促使食品加工商从传统的培养方法转向先进的自动化系统，以确保合规并避免代价高昂的停产。例如，2024年4月，美国农业部食品安全检验局（FSIS）最终确定了一项政策，规定即使每克生鸡肉製品中仅含有一个菌落形成单位（CFU）的沙门氏菌，也将被视为「掺假」。这项法规直接催生了能够以极高的准确度检测微量污染的诊断检测套组的出现。

同时，沙门氏菌疫情和食源性疾病的不断增加，持续推动整个供应链对快速病原体检测的需求。国际食品贸易的扩张增加了交叉污染的可能性，导致频繁的大规模召回，需要在关键控制点进行严格的检测。美国疾病管制与预防中心 (CDC) 于 2024 年 11 月发布的一份关于黄瓜相关沙门氏菌疫情的最新报告显示，在多州联合调查中确认了 68 例病例，凸显了新鲜农产品面临的持续威胁。为了应对这些财务和声誉风险，各公司正在加强其检验程序。根据 Sedgwick 于 2024 年 5 月发布的《2024 年召回指数报告》，2024 年第一季美国食品药物管理局 (FDA) 的食品召回数量环比增长 27.6%，凸显了建立健全的病原体检测基础设施的迫切需求。

市场挑战

先进分子诊断平台高昂的营运成本是全球沙门氏菌检测市场扩张的主要障碍。这些先进的侦测系统需要大量的资金投入，包括设备、专用耗材以及员工技术培训。对于在价格敏感型市场中营运的中小型食品生产商和加工商而言，这些费用往往超出其负担能力。这种经济压力限制了自动化检测技术的广泛应用，迫使许多营业单位依赖劳动密集且效率低下的传统方法，从而阻碍了发展中地区市场的均衡成长，因为这些地区的利润率不足以支撑此类基础设施的运作。

这种成本障碍直接影响产业有效管理病原体风险的能力，因为依赖廉价但缓慢的诊断方法会延迟对受污染产品的识别。 2024年，美国疾病管制与预防中心（CDC）监测并调查了10起与各种食品相关的跨州沙门氏菌集体爆发，显示病原体控制仍然不稳定。小规模的市场参与者无法负担实施和营运快速、高精度检测系统的费用，这在全球供应链中造成了脆弱性，最终阻碍了先进诊断解决方案的潜在市场扩张。

市场趋势

全基因测序(WGS) 的广泛应用正在改变全球沙门氏菌检测市场，它以高解析度基因组分析取代了传统的表型分型技术。实验室越来越多地利用 WGS 在单次检测中识别血清型、毒力因子和抗菌素抗药性谱，从而显着提高了污染事件发生时溯源的准确性。这项技术革新得益于分散式网路的支持，该网路能够实现即时跨境资料共用，从而更有效地识别污染源。例如，根据美国食品药物管理局 (FDA) 2025 年 12 月发布的“GenomeTrakr 快速概览”，该网络目前每月常规定序超过 20,000 个分离株，这表明正在大规模推进将先进的基因组技术整合到标准食品安全监测体系中。

同时，能够一次检测同时识别多种沙门氏菌菌株和合併感染疾病的多病原体检测组合的需求日益增长。这一趋势正在加速从人工培养技术向自动化分子平台的过渡，简化综合征检测流程并加快检测速度。食品加工商和临床实验室越来越倾向于使用这些综合检测组合，以提高诊断准确性和营运效率。生物梅里埃公司于2025年3月发布的2024财年财务业绩报告也反映了这一转变，报告显示其包含消化器官系统检测组合的销售额增长了17%。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球沙门氏菌检测市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依检测方法（培养法、分子生物学方法、免疫检测）
  • 依样品类型（食品、水、环境表面）
  • 按最终用户（食品生产商/製造商、合约检测实验室、政府/监管机构、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美沙门氏菌检测市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲沙门氏菌检测市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区沙门氏菌检测市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲沙门氏菌检测市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美沙门氏菌检测市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球沙门氏菌检测市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific Inc.
• BioMerieux SA
• Merck KGaA
• QIAGEN NV
• Eurofins Scientific
• Hardy Diagnostics
• PerkinElmer AES
• Mylab Discovery Solutions Pvt. Ltd.
• Abbott Laboratories Inc.
• Biomerica, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Salmonella Testing Market is projected to expand from USD 3.31 Billion in 2025 to USD 4.72 Billion by 2031, registering a CAGR of 6.09%. This market encompasses diagnostic technologies, consumables, and procedural methods designed to identify Salmonella bacteria across food items, beverages, water sources, and clinical samples. Key factors driving this growth include increasingly strict international food safety laws, a growing global frequency of foodborne illness outbreaks, and escalating consumer insistence on transparent food hygiene practices. Consequently, rigorous pathogen screening is mandated throughout the supply chain, creating a critical need for dependable and fast detection solutions to avert contamination and safeguard public health.

Despite these growth prospects, the market encounters significant obstacles due to the substantial operational costs tied to advanced molecular diagnostic platforms, which limit adoption in cost-sensitive developing areas. Data from the National Chicken Council in 2024 revealed that 97 percent of whole birds and 93 percent of chicken parts tested negative for Salmonella at processing facilities, demonstrating the immense volume of testing required to uphold these safety levels. While these results highlight the industry's dependence on continuous verification, the financial strain associated with such comprehensive testing programs continues to act as a formidable barrier for smaller market participants.

Market Driver

The enforcement of rigorous government food safety regulations serves as a major driver for the expansion of the Global Salmonella Testing Market. Regulatory authorities across the globe are setting lower tolerance thresholds and implementing "zero-tolerance" mandates for specific serotypes, which compels manufacturers to implement highly sensitive molecular screening protocols. This legislative environment forces food processors to transition from traditional culture methods to sophisticated automated systems to guarantee compliance and prevent expensive operational shutdowns. For instance, the USDA Food Safety and Inspection Service finalized a policy in April 2024 declaring that raw breaded stuffed chicken products containing as little as 1 colony forming unit per gram of Salmonella are considered adulterated, a mandate that directly necessitates the acquisition of diagnostic assays capable of detecting low-level contamination with extreme accuracy.

Simultaneously, the rising incidence of Salmonella outbreaks and foodborne diseases sustains the demand for rapid pathogen testing throughout the supply chain. As global food trade widens, the potential for cross-contamination increases, resulting in frequent large-scale recalls that require strict testing at critical control points. According to a November 2024 update from the Centers for Disease Control and Prevention regarding a Salmonella outbreak linked to cucumbers, a multistate investigation identified 68 infected individuals, emphasizing the ongoing threat in fresh produce. To counter these financial and reputational dangers, companies are strengthening their verification programs; the Sedgwick "2024 Recall Index report" from May 2024 noted that FDA food recalls rose by 27.6 percent in the first quarter of 2024 compared to the prior quarter, highlighting the essential need for strong pathogen detection infrastructure.

Market Challenge

The substantial operational expenditure associated with advanced molecular diagnostic platforms represents a major obstacle to the expansion of the Global Salmonella Testing Market. These sophisticated testing systems require significant capital investment for equipment, specialized consumables, and the technical training of staff. For smaller food manufacturers and processors operating within price-sensitive markets, these expenses often surpass their financial capabilities. This economic pressure limits the broad adoption of automated detection technologies, forcing many entities to rely on labor-intensive and slower legacy methods, which in turn hampers uniform market growth in developing regions where profit margins cannot sustain such infrastructure.

This cost-related barrier directly impacts the industry's capacity to effectively manage pathogen risks, as reliance on cheaper, slower diagnostic methods can retard the identification of contaminated products. In 2024, the Centers for Disease Control and Prevention monitored and investigated 10 separate multistate Salmonella outbreaks associated with various food items, illustrating the continuing volatility of pathogen control. The inability of smaller market players to afford and implement rapid, high-precision testing systems generates vulnerabilities within the global supply chain, ultimately stifling the broader market potential for advanced diagnostic solutions.

Market Trends

The extensive adoption of Whole Genome Sequencing (WGS) is transforming the Global Salmonella Testing Market by supplanting traditional phenotypic subtyping techniques with high-resolution genomic analysis. Laboratories are increasingly employing WGS to identify serotypes, virulence factors, and antimicrobial resistance profiles within a single assay, thereby greatly improving the accuracy of source tracking during contamination incidents. This technological evolution is bolstered by distributed networks that facilitate real-time cross-border data sharing to more effectively identify outbreak origins; for example, the FDA's "GenomeTrakr Fast Facts" from December 2025 indicates that the network is now routinely sequencing over 20,000 isolates monthly, showcasing the massive scale of integrating advanced genomic technology into standard food safety surveillance.

In parallel, there is a growing demand for multiplex pathogen detection panels, which allow for the simultaneous identification of multiple Salmonella strains and co-infections in a single test run. This trend is accelerating the shift from manual culture techniques to automated molecular platforms that provide streamlined workflows and faster turnaround times for syndromic testing. Food processors and clinical laboratories are increasingly preferring these comprehensive panels to enhance diagnostic precision and operational efficiency, a shift reflected in bioMerieux's March 2025 "2024 Financial Results," which reported a 17 percent increase in sales of BIOFIRE non-respiratory panels, including gastrointestinal testing solutions.

Key Market Players

• Thermo Fisher Scientific Inc.
• BioMerieux SA
• Merck KGaA
• QIAGEN N.V.
• Eurofins Scientific
• Hardy Diagnostics
• PerkinElmer AES
• Mylab Discovery Solutions Pvt. Ltd.
• Abbott Laboratories Inc.
• Biomerica, Inc.

Report Scope

In this report, the Global Salmonella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Salmonella Testing Market, By Testing Method

• Culture-based Methods
• Molecular-based Methods
• Immunoassays

Salmonella Testing Market, By Sample Type

• Food
• Water
• Environmental Surfaces

Salmonella Testing Market, By End User

• Food Producers and Manufacturers
• Contract Testing Laboratories
• Government and Regulatory Bodies
• Others

Salmonella Testing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Salmonella Testing Market.

Available Customizations:

Global Salmonella Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Salmonella Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Testing Method (Culture-based Methods, Molecular-based Methods, Immunoassays)
  • 5.2.2. By Sample Type (Food, Water, Environmental Surfaces)
  • 5.2.3. By End User (Food Producers and Manufacturers, Contract Testing Laboratories, Government and Regulatory Bodies, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Salmonella Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Testing Method
  • 6.2.2. By Sample Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Salmonella Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Testing Method
      • 6.3.1.2.2. By Sample Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Salmonella Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Testing Method
      • 6.3.2.2.2. By Sample Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Salmonella Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Testing Method
      • 6.3.3.2.2. By Sample Type
      • 6.3.3.2.3. By End User

7. Europe Salmonella Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Testing Method
  • 7.2.2. By Sample Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Salmonella Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Testing Method
      • 7.3.1.2.2. By Sample Type
      • 7.3.1.2.3. By End User
  • 7.3.2. France Salmonella Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Testing Method
      • 7.3.2.2.2. By Sample Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Salmonella Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Testing Method
      • 7.3.3.2.2. By Sample Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Salmonella Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Testing Method
      • 7.3.4.2.2. By Sample Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Salmonella Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Testing Method
      • 7.3.5.2.2. By Sample Type
      • 7.3.5.2.3. By End User

8. Asia Pacific Salmonella Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Testing Method
  • 8.2.2. By Sample Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Salmonella Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Testing Method
      • 8.3.1.2.2. By Sample Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Salmonella Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Testing Method
      • 8.3.2.2.2. By Sample Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Salmonella Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Testing Method
      • 8.3.3.2.2. By Sample Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Salmonella Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Testing Method
      • 8.3.4.2.2. By Sample Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Salmonella Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Testing Method
      • 8.3.5.2.2. By Sample Type
      • 8.3.5.2.3. By End User

9. Middle East & Africa Salmonella Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Testing Method
  • 9.2.2. By Sample Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Salmonella Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Testing Method
      • 9.3.1.2.2. By Sample Type
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Salmonella Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Testing Method
      • 9.3.2.2.2. By Sample Type
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Salmonella Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Testing Method
      • 9.3.3.2.2. By Sample Type
      • 9.3.3.2.3. By End User

10. South America Salmonella Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Testing Method
  • 10.2.2. By Sample Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Salmonella Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Testing Method
      • 10.3.1.2.2. By Sample Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Salmonella Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Testing Method
      • 10.3.2.2.2. By Sample Type
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Salmonella Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Testing Method
      • 10.3.3.2.2. By Sample Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Salmonella Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. BioMerieux SA
• 15.3. Merck KGaA
• 15.4. QIAGEN N.V.
• 15.5. Eurofins Scientific
• 15.6. Hardy Diagnostics
• 15.7. PerkinElmer AES
• 15.8. Mylab Discovery Solutions Pvt. Ltd.
• 15.9. Abbott Laboratories Inc.
• 15.10. Biomerica, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer